Announced Mon, 11 May · 11:43 IST
OUTCOME OF EXTRA-ORDINARY GENERAL MEETING OF THE COMPANY
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹20.50
prior close
₹21.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+0.0+0.0+1.0+3.2-2.0-2.0+4.8+12.4+7.2—
Up moveDown movePending
AI summary
Beryl Drugs Limited held an EGM on May 11, 2026 where shareholders approved three items. The meeting appointed Mr. Shailendra Pathak as a whole-time director and Mrs. Neha Sarda as a non-executive independent director. Additionally, members approved material related party transactions with M/s. Aminova Infusions Pvt. Ltd. The meeting lasted 30 minutes, concluding at 11:30 AM.
Likely market impact
The appointment of two new directors may bring fresh perspective to the board. However, the approval of material related party transactions with Aminova Infusions requires monitoring for fair terms and potential conflicts of interest.